Evidence map›Paper›PMID 33352732›Full record

ReviewLife (Basel, Switzerland)2020

The Role of Connexin 43 in Lung Disease.

Julie A Swartzendruber, Bruce J Nicholson, Ashlesh K Murthy

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Julie A SwartzendruberDepartment of Microbiology and Immunology, College of Graduate Studies, Midwestern University, Downers Grove, IL 60515, USA.ORCID 0000-0002-1598-9267
Bruce J NicholsonDepartment of Biochemistry, School of Medicine, University of Texas Health Science Center, San Antonio, TX 78299, USA.
Ashlesh K MurthyCollege of Veterinary Medicine, Midwestern University, Glendale, AZ 85308, USA.ORCID 0000-0003-4685-6122
Midwestern University · USThe University of Texas Health Science Center at San Antonio · US

Funding

MECHANISM(S) OF CD8 T CELL-MEDIATED CHLAMYDIA-INDUCED REPRODUCTIVE PATHOLOGYR15AI101920 · NIAID · MIDWESTERN UNIVERSITY (GLENDALE AZ) · PI LI, WEIDANG · 2013 to 2019
$1.4M
NIAID NIH HHS R15 AI101920NIH HHS 2R15AI101920-02NIH HHS 2R16AI101920-03
6 · The paper itself

Abstract

The term lung disease describes a broad category of disorders that impair lung function. More than 35 million Americans have a preventable chronic lung disease with high mortality rates due to limited treatment efficacy. The recent increase in patients with lung disease highlights the need to increase our understanding of mechanisms driving lung inflammation. Connexins, gap junction proteins, and more specifically connexin 43 (Cx43), are abundantly expressed in the lung and are known to play a role in lung diseases. This review focuses on the role of Cx43 in pathology associated with acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD) and asthma. Additionally, we discuss the role of Cx43 in preventing disease through the transfer of mitochondria between cells. We aim to highlight the need to better understand what cell types are expressing Cx43 and how this expression influences lung disease.

Indexed as

acute respiratory distress syndromeasthmaconnexin 43gap junction proteinsmitochondria

Identifiers

PMID33352732
PMCPMC7766413
OpenAlexW3115697078

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.